CN111100151A - Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA - Google Patents
Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA Download PDFInfo
- Publication number
- CN111100151A CN111100151A CN201911318427.5A CN201911318427A CN111100151A CN 111100151 A CN111100151 A CN 111100151A CN 201911318427 A CN201911318427 A CN 201911318427A CN 111100151 A CN111100151 A CN 111100151A
- Authority
- CN
- China
- Prior art keywords
- probe
- parallel configuration
- compound
- dna
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091081406 G-quadruplex Proteins 0.000 title claims abstract description 52
- 239000000523 sample Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 238000001514 detection method Methods 0.000 claims abstract description 16
- 108020004414 DNA Proteins 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 239000011259 mixed solution Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 108020003215 DNA Probes Proteins 0.000 claims description 9
- 239000003298 DNA probe Substances 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 238000002189 fluorescence spectrum Methods 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 230000001588 bifunctional effect Effects 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229940126214 compound 3 Drugs 0.000 claims description 7
- 229940125898 compound 5 Drugs 0.000 claims description 7
- -1 ether oxygen chain modified p-hydroxybenzaldehyde Chemical class 0.000 claims description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- MFFMQGGZCLEMCI-UHFFFAOYSA-N 2,4-dimethyl-1h-pyrrole Chemical compound CC1=CNC(C)=C1 MFFMQGGZCLEMCI-UHFFFAOYSA-N 0.000 claims description 3
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 claims description 3
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims description 3
- PAPNRQCYSFBWDI-UHFFFAOYSA-N DMP Natural products CC1=CC=C(C)N1 PAPNRQCYSFBWDI-UHFFFAOYSA-N 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 229940125904 compound 1 Drugs 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 230000003595 spectral effect Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 230000007547 defect Effects 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002211 ultraviolet spectrum Methods 0.000 description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 4
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 4
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091035539 telomere Proteins 0.000 description 2
- 102000055501 telomere Human genes 0.000 description 2
- 210000003411 telomere Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- YPSXFMHXRZAGTG-UHFFFAOYSA-N 4-methoxy-2-[2-(5-methoxy-2-nitrosophenyl)ethyl]-1-nitrosobenzene Chemical compound COC1=CC=C(N=O)C(CCC=2C(=CC=C(OC)C=2)N=O)=C1 YPSXFMHXRZAGTG-UHFFFAOYSA-N 0.000 description 1
- 101100327819 Caenorhabditis elegans chl-1 gene Proteins 0.000 description 1
- 101100484538 Caenorhabditis elegans vav-1 gene Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102100029974 GTPase HRas Human genes 0.000 description 1
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101100257637 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) trf-2 gene Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 101150039863 Rich gene Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004791 biological behavior Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000033863 telomere maintenance Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a preparation method of a probe for specifically detecting a parallel configuration G-quadruplex DNA, belonging to the technical field of biological probes. The specific structural formula of the related probe is as follows:the probe has the advantages of simple preparation steps, easily obtained raw materials and low fluorescence background. The rapid dual-function specificity detection of the parallel configuration G-quadruplex DNA can be realized by an ultraviolet spectrophotometer and a fluorescence spectrophotometer. Overcomes the defects of single and difficult differentiation of G-quadruplex DNA with different configurations of the traditional detection method, and has the advantages of simple structure, low cost, high specificityHas wide application prospect.
Description
Technical Field
The invention relates to construction of a novel bifunctional probe, a preparation method and application thereof, belonging to the technical field of biological probes.
Background
The G-quadruplex DNA is a special DNA structure, and is a high-level DNA secondary structure formed by self-assembling four guanine rings of a guanine-rich DNA sequence into a G-tetrad through Hoogsteen hydrogen bonds under a certain condition and forming two or more G-tetrads through pi-pi stacking action. The G-quadruplexes can be divided into three different structures, i.e., parallel, antiparallel and mixed, according to the orientation of the four chains in the G-quadruplexes. Recent bioinformatics studies have shown that approximately 37 million guanine-rich gene sequences, which may form a G-quadruplex structure in humans, are common, particularly in the telomere ends and oncogene promoter regions of humans (e.g., c-myc, ckit, bcl-2, Pu27, kRAS, VEGFR, TERT, etc.). This "new" DNA structure is widely distributed in eukaryotic genomes, such as telomere ends, rDNA, and gene promoter regions. Biological function research shows that the structure relates to the processes of DNA replication, telomere maintenance, gene expression and regulation, and the like, and is closely related to the proliferation and apoptosis of cells and the occurrence and development of tumors. However, only a few G-quadruplex DNAs have been studied in detail so far. Therefore, the construction and related action research of the probe molecule with the specific recognition G-quadruplex DNA structure lays a foundation for understanding the distribution, the function and the mechanism of the structure in the gene, and provides a new opportunity for specifically regulating and controlling the cell biological behavior.
Fluorescence imaging is widely applied to molecular detection as an intuitive and in-situ visual observation technology. The molecular fluorescent probe based on the organic fluorophore has the advantages of high sensitivity, simplicity and convenience in operation, good reproducibility and the like, can be conveniently used for in-situ real-time nondestructive detection of target molecules in a biological system, is used for monitoring biomolecules and biological processes of living cells and living bodies, and increasingly becomes an indispensable molecular tool in the fields of modern life science, disease diagnosis and the like. To date, the detection of many small molecule probes targeting the G-quadruplex DNA structure in vitro and even in vivo has made a number of important research advances. But more problems need to be solved in practical application due to the complex in vivo environment. The G-quadruplex DNA structure is very small in the whole genome and almost submerged in the sea of double helix DNA. Furthermore, the secondary structure of G-quadruplex DNA is complex and diverse, including parallel, antiparallel and mixed configurations. Thus, there are few reports on the ability of probe molecules to selectively detect G-quadruplex DNA structures, even one type of configuration. Most reported probes have single means for detecting G-quadruplex DNA conformation research and have larger interference.
In recent years, BODIPY (BODIPY) is an ideal bioluminescent probe which is widely researched and applied and has excellent optical properties such as low biotoxicity, adjustable fluorescence characteristics, insensitivity to environment, strong photo-thermal stability and the like. The applicant synthesizes a series of aryl ethylene compounds with conjugated functional side chains in the early stage, and the aryl ethylene compounds have better binding capacity to G-quadruplex DNA. The applicant combines a functional side chain into a BODIPY skeleton structure to obtain a novel G-quadruplex DNA probe molecule with a bifunctional detection parallel configuration.
Disclosure of Invention
The invention aims to provide a synthetic method of a G-quadruplex DNA probe with a double-function detection parallel configuration and application thereof aiming at the defects of the prior art.
The invention provides a G-quadruplex DNA probe with a bifunctional detection parallel configuration, which has the following structural formula:
the invention relates to a preparation method of a G-quadruplex DNA probe with a bifunctional detection parallel configuration, which has the following reaction equation:
the invention relates to a preparation method of a G-quadruplex DNA probe with a double-function detection parallel configuration, which comprises the following steps:
(1) under the protection of nitrogen, using anhydrous dichloromethane as a solvent, reacting ether oxygen chain modified p-hydroxybenzaldehyde (compound 1) with 2, 4-dimethylpyrrole, 2, 3-dichloro-5, 6-dicyano-p-benzoquinone, boron trifluoride diethyl ether and triethylamine in a molar ratio of 1:2:1:30:35 under stirring at room temperature, and separating and purifying a product to obtain a compound 3. The structural formula of compound 3 is:
(2) dissolving the compound 4, 4-fluorobenzaldehyde and potassium carbonate in anhydrous acetonitrile according to the molar ratio of 1:1:3, performing reflux reaction, and separating and purifying a product to obtain a compound 5. The structural formula of compound 4 is:
the structural formula of compound 5 is:
(3) dissolving the compound 3, the compound 5, piperidine and glacial acetic acid in toluene according to the molar ratio of 1:1:10:10, reacting at 130 ℃, and separating and purifying the product to obtain the final probe compound. The structural formula of the probe compound is:
the invention also provides application of the fluorescent probe in selective recognition of G-quadruplex DNA with parallel configuration.
The method comprises the following steps:
1) dissolving a G-quadruplex DNA probe with a dual-function detection parallel configuration by using DMSO, and diluting by using a buffer solution with pH7.4 to obtain a solution B; the DNA sample to be tested was dissolved in a buffer solution of pH 7.4.
2) And mixing the solution B and the solution A to ensure that the molar ratio of the DNA sample to be detected to the probe in the mixed solution is 2-1, analyzing the spectral change of the mixed solution by using a fluorescence spectrophotometer or an ultraviolet spectrophotometer to judge whether the DNA sample to be detected is a G-quadruplex DNA structure with a parallel configuration. The judgment method comprises the following steps:
(a) when the mixed solution is analyzed by a fluorescence spectrophotometer, compared with the solution B, if the fluorescence intensity of the fluorescence spectrum of the mixed solution at 606nm is obviously enhanced (the enhancement range is 150-250 times), the DNA sample to be detected can be judged to be a G-quadruplex DNA structure with parallel configuration; if the fluorescence intensity of the mixed solution is not obviously enhanced (less than 150 times) relative to that of the solution B, the detected DNA sample can be judged to be a G-quadruplex DNA structure with a non-parallel configuration.
(b) When the mixed solution is analyzed by an ultraviolet spectrophotometer, compared with the solution B, if the absorption spectrum of the mixed solution has an obvious new peak at 584nm (A: A)0>1.05) and the peak width is narrowed, the G-quadruplex DNA structure of the parallel configuration of the DNA sample to be detected can be judged; if the absorbance spectrum of the mixed solution does not change or decreases with respect to that of solution B (A: A)0<1.05), the detected DNA sample can be judged to be a G-quadruplex DNA structure with a non-parallel configuration.
Compared with the prior art, the invention has the following advantages:
the probe preparation synthetic route has strong operability, easily obtained raw materials and low preparation cost. And the parallel G-quadruplex DNA structure can be detected with dual-function specificity through ultraviolet spectrum or fluorescence spectrum, so that the parallel G-quadruplex DNA structure can be distinguished from other antiparallel G-quadruplex, single-strand and double-strand DNA structures. Overcomes the defects of single and difficult differentiation of G-quadruplex DNA with different configurations in the traditional detection method
Drawings
FIG. 1 is a UV spectrum of probe-titrated parallel configuration G-quadruplex DNA (c-myc);
FIG. 2 is a fluorescence spectrum of probe-titrated parallel configuration G-quadruplex DNA (c-myc);
FIG. 3 is an ultraviolet spectrum of probe-titrated antiparallel configuration G-quadruplex DNA (Oxy 28);
FIG. 4 is a fluorescence spectrum of probe-titrated antiparallel configuration G-quadruplex DNA (Oxy 28);
FIG. 5 is a UV spectrum of probe-titrated double-stranded DNA (ds 26);
FIG. 6 is a fluorescence spectrum of probe-titrated double-stranded DNA (ds 26);
FIG. 7 shows UV spectra of probe-titrated single-stranded DNA (ss 26);
FIG. 8 shows fluorescence spectra of probe-titrated single-stranded DNA (ss 26);
FIG. 9 shows the ultraviolet (A/A) of a probe for DNAs of different structures0) A dot plot of responses;
FIG. 10 shows fluorescence (F/F) of different structural DNAs with a probe0) Histogram of the response.
Detailed Description
The present invention will be further described with reference to the following detailed description and accompanying drawings so that those skilled in the art can better understand the technical solution of the present invention.
Example 1: synthesis of Compound 3
Under the protection of nitrogen, 1.0g (3.7mmol) of ether oxygen chain modified p-hydroxybenzaldehyde (compound 1) and 0.7g (7.4mmol) of 2, 4-dimethylpyrrole are dissolved in 100mL of anhydrous dichloromethane, 3-5 drops of a catalytic amount of trifluoroacetic acid are added dropwise, and the mixture is stirred at room temperature for 12 hours, then 0.84g (3.7mmol) of 2, 3-dichloro-5, 6-dicyano-p-benzoquinone is added, and the mixture is stirred for 12 hours, 18mL (129mmol) of triethylamine is added, the mixture is stirred for 30 minutes, 15mL (118.0mmol) of boron trifluoride diethyl ether is added, and the mixture is stirred for 8 hours. Washing with ultrapure water (25mL × 2 times) and saturated NaCl aqueous solution (25mL × 2 times) in this order, drying the obtained organic phase with anhydrous sodium sulfate, and distilling off dichloromethane under reduced pressure to obtain a crude product, which is subjected to column chromatography purification using a mixed solvent of ethyl acetate and petroleum ether at a volume ratio of 1:1 as a mobile phase and silica gel as a stationary phase, to obtain 0.45g of red solid product 3 with a yield of 24.8%.1H NMR(400MHz,CDCl3)δ:7.16(m,2H),7.02(m,2H),5.97(s,2H),4.18(t,J=4.6Hz,2H),3.91(t,J=4.88Hz,2H),3.78-3.75(m,2H),3.72-3.65(m,4H),3.57-3.55(m,2H),3.38(s,3H),2.54(s,6H),1.42(s,6H)。
Example 2: synthesis of Compound 5
0.65g (5.0mmol) of N-hydroxyethylpiperazine was dissolved in 50mL of DMSO, 0.62g (5.0mmol) of 4-fluorobenzaldehyde and 2.0g (15.0mmol) of K were added2CO3The reaction was heated in an oil bath at 100 ℃ for 24 hours. After the reaction, 100mL of water was added, extraction was performed with dichloromethane (50 mL. times.3 times), the resulting organic phase was dried over anhydrous sodium sulfate, dichloromethane was distilled off under reduced pressure, and the crude product was obtained in a volume ratio of ethyl acetate to petroleum etherAnd (3) performing column chromatography purification by using a mixed solvent of 2:1 as a mobile phase and silica gel as a stationary phase to obtain 0.80g of a yellow solid product 5, wherein the yield is 68.3%.
Example 3: synthesis of Probe
0.4g (0.82mmol) of Compound 3, 0.19g (0.82mmol) of Compound 5, 0.8mL of glacial acetic acid, and 1mL of piperidine were dissolved in 50mL of toluene, and heated to 120 ℃ for reaction for 8 hours. After the reaction, the toluene was distilled off under reduced pressure, and the obtained crude product was purified by column chromatography using a mixed solvent of dichloromethane and methanol in a volume ratio of 20:1 as a mobile phase and silica gel as a stationary phase to obtain 0.21g of a dark blue solid product probe, with a yield of 36.8%.1H NMR(400MHz,CDCl3)δ:7.54-7.49(m,3H),7.19-7.15(m,3H),7.02(d,J=8.24Hz,2H),6.88(d,J=8.56Hz,2H),6.57(s,1H),5.98(s,1H),4.19(t,J=4.28Hz,2H),3.91(t,J=4.64Hz,2H),3.78-3.76(m,6H),3.70-3.66(m,4H),3.57-3.55(m,2H),3.38(m,5H),2.86(br,4H),2.76(m,2H),2.57(s,3H),1.46(s,3H),1.42(s,3H);19FNMR(376MHz,CDCl3) δ: -139.66, -139.73, -139.84, -139.92; HRMS (ESI) m/z: theoretical value C39H50BF2N4O5[M+H]+703.3842; experimental value, 703.3831.
Example 4: application of the Probe of the present invention
(1) Preparation of DNA samples. DNA samples were purchased from Shanghai Producers, Inc. The DNA sample was dissolved in an appropriate amount of buffer solution (10mM Tris-HCl, containing 60mM KCl) at pH 7.4.
The parallel configuration G-quadruplex DNA sequence used in this experiment is:
sequence number CM 22: 5'-TGAGGGTGGGTAGGGTGGGTAA-3'
Sequence number c-myc: 5'-TTGAGGGTGGGTAGGGTGGGTAAA-3'
Sequence number Ckit 1: 5'-AGGGAGGGCGCTGGGAGGAGGG-3'
Sequence number TRF 2: 5'-CGGGAGGGCGGGGAGGGC-3'
Sequence number Chl 1: 5'-CGGGCGGGGAAGGGGTGGGA-3'
Sequence number VAV 1: 5'-GGGCAGGGAGGGAACTGGG-3'
Sequence number Bcl 2: 5'-GGGCGGGCGCGGGAGGAAGGGGGCGGG-3'
Sequence number EAD: 5'-CTGGGTGGGTGGGTGGGA-3'
Sequence number Pu 27: 5'-TGGGGAGGGTGGGGAGGGTGGGGAAGG-3'
The antiparallel G-quadruplex DNA sequence used in this experiment was:
sequence number Ckit: 5'-GGCGAGGAGGGGCGTGGCCGGC-3'
Sequence number HRAS: 5'-TCGGGTTGCGGGCGCAGGGCACGGGCG-3'
Sequence number Hum 24: 5'-TTAGGGTTAGGGTTAGGGTTAGGG-3'
Sequence number ASC 20: 5'-GGCTTAGGCTTAGGCTTAGG-3'
Sequence number ODN: 5'-GGGATGGGACACAGGGGACGGG-3'
Sequence number Oxy 28: 5'-GGGGTTTTGGGGTTTTGGGGTTTTGGGG-3'
The double-stranded DNA sequences used in this experiment were:
sequence number ds 26: 5'-CAATCGGATCGAATTCGATCCGATTG-3'
Sequence number d (A-T)2:5’-GCATGCGCGCGCGCATGC-3’
Sequence number d (A-T)5:5’-GCGCATATATATATGCGC-3’
Sequence number d (A-T)9:5’-ATATATATATATATATAT-3’
Sequence number d (G-C)9:5’-GCGCGCGCGCGCGCGCGC-3’
The single-stranded DNA sequences used in this experiment were:
sequence number ss 26: 5'-CCGCGAACGCCTAAGCTGCTAACCGC-3'
(2) And (3) preparing a probe solution. The probes were formulated as stock solutions in DMSO solvent and diluted with 10mM Tris-HCl buffer (pH 7.4, containing 60mM KCl) for testing.
(3) And (5) detecting by ultraviolet spectrum. The concentration of the fixed fluorescent probe solution is 2 mu M, different DNA samples are respectively dripped into the probe solution, the probe solution is stabilized for 1 minute after being homogenized, and the absorption spectrum of the system is measured by an ultraviolet spectrophotometer. The titration experiment result is shown in figures 1, 3, 5, 7 and 9, if a new absorption peak is generated at 584nm of the test sample, and the absorbance increase multiple at 584nm is more than 1.05 times, the DNA sample to be detected can be judged to be a G-quadruplex DNA structure with parallel configuration; if the absorbance of the mixture is not changed or decreased and the absorbance at 584nm is increased by a factor of less than 1.05, the detected DNA sample can be determined to be a G-quadruplex DNA structure with a non-parallel configuration.
(4) And (4) detecting fluorescence spectrum. The concentration of the fixed fluorescent probe solution is 1 mu M, different DNA samples are respectively dripped into the probe solution, the probe solution is stabilized for 1 minute after being homogenized, the fluorescence emission of the system is measured by using a fluorescence spectrum, and 575nm is set as an excitation wavelength. The titration experiment results are shown in FIGS. 2,4, 6, 8 and 10, if the fluorescence intensity of the system at 605nm is enhanced by more than 150 times, the DNA sample to be detected can be judged to be a parallel configuration G-quadruplex DNA structure; if the fluorescence intensity of the system is less than 150 times, the DNA sample to be detected can be judged to be in a non-parallel configuration G-quadruplex structure.
Claims (3)
2. the method for preparing the G-quadruplex DNA probe with the bifunctional detection parallel configuration according to claim 1, which is characterized by comprising the following steps:
(1) under the protection of nitrogen, taking anhydrous dichloromethane as a solvent, reacting ether oxygen chain modified p-hydroxybenzaldehyde (compound 1) with 2, 4-dimethylpyrrole, 2, 3-dichloro-5, 6-dicyano-p-benzoquinone, boron trifluoride diethyl ether and triethylamine in a molar ratio of 1:2:1:30:35 by stirring at room temperature, and separating and purifying a product to obtain a compound 3; the structural formula of compound 3 is:
(2) dissolving the compound 4, 4-fluorobenzaldehyde and potassium carbonate in anhydrous acetonitrile according to the molar ratio of 1:1:3, performing reflux reaction, and separating and purifying a product to obtain a compound 5; the structural formula of compound 4 is:
the structural formula of compound 5 is:
(3) dissolving the compound 3, the compound 5, piperidine and glacial acetic acid in toluene according to the molar ratio of 1:1:10:10, reacting at 130 ℃, and separating and purifying a product to obtain a final probe compound; the structural formula of the probe compound is:
3. the use of the bifunctional G-quadruplex DNA detection probe with the parallel configuration as claimed in claim 1 for detecting G-quadruplex DNA, which is carried out according to the following steps:
1) dissolving a G-quadruplex DNA probe with a dual-function detection parallel configuration by using DMSO, and diluting by using a buffer solution with pH7.4 to obtain a solution B; dissolving a DNA sample to be detected by using a buffer solution with pH 7.4;
2) mixing the solution B and the solution A to enable the molar ratio of the DNA sample to be detected to the probe in the mixed solution to be 2-1, analyzing the spectral change of the mixed solution by using a fluorescence spectrophotometer or an ultraviolet spectrophotometer to judge whether the DNA sample to be detected is a G-quadruplex DNA structure with a parallel configuration; the judgment method comprises the following steps:
(a) when the mixed solution is analyzed by a fluorescence spectrophotometer, compared with the solution B, if the fluorescence intensity of the fluorescence spectrum of the mixed solution at 606nm is obviously enhanced (the enhancement range is 150-250 times), the DNA sample to be detected can be judged to be a G-quadruplex DNA structure with parallel configuration; if the fluorescence intensity of the mixed solution is not obviously enhanced (less than 150 times) relative to that of the solution B, the detected DNA sample can be judged to be a G-quadruplex DNA structure with a non-parallel configuration;
(b) when the mixed solution is analyzed by an ultraviolet spectrophotometer, compared with the solution B, if the absorption spectrum of the mixed solution has an obvious new peak at 584nm (A: A)0>1.05) and the peak width is narrowed, the G-quadruplex DNA structure of the parallel configuration of the DNA sample to be detected can be judged; if the absorbance spectrum of the mixed solution does not change or decreases with respect to that of solution B (A: A)0<1.05), the detected DNA sample can be judged to be a G-quadruplex DNA structure with a non-parallel configuration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911318427.5A CN111100151B (en) | 2019-12-19 | 2019-12-19 | Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911318427.5A CN111100151B (en) | 2019-12-19 | 2019-12-19 | Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111100151A true CN111100151A (en) | 2020-05-05 |
CN111100151B CN111100151B (en) | 2022-04-26 |
Family
ID=70423015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911318427.5A Active CN111100151B (en) | 2019-12-19 | 2019-12-19 | Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111100151B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109796483A (en) * | 2019-03-11 | 2019-05-24 | 福州大学 | A kind of water-soluble cationic photosensitizer and its preparation and application |
-
2019
- 2019-12-19 CN CN201911318427.5A patent/CN111100151B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109796483A (en) * | 2019-03-11 | 2019-05-24 | 福州大学 | A kind of water-soluble cationic photosensitizer and its preparation and application |
Non-Patent Citations (1)
Title |
---|
ZHANG, JINGTUO ET AL: "Near-infrared fluorescent probes based on piperazine-functionalized BODIPY dyes for sensitive detection of lysosomal pH", 《JOURNAL OF MATERIALS CHEMISTRY B: MATERIALS FOR BIOLOGY AND MEDICINE》 * |
Also Published As
Publication number | Publication date |
---|---|
CN111100151B (en) | 2022-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111423423B (en) | Application of ratiometric fluorescent probe in detecting peroxynitrite anion | |
CN110172337B (en) | Benzothiazole derivative fluorescent probe and preparation method and application thereof | |
CN102146284B (en) | Ratiometric fluorescent probe and application thereof | |
CN111518089B (en) | Ratio type fluorescent probe for detecting pH, and preparation method and application thereof | |
Peng et al. | A novel fluorescent probe for selective detection of hydrogen sulfide in living cells | |
CN109735328A (en) | A kind of fluorescence probe and its preparation method and application detecting intracellular hydrogen sulfide | |
CN109293669B (en) | Fluorescent probe for detecting hypochlorous acid and synthetic method and application thereof | |
CN113801105B (en) | Mitochondrion targeted peroxynitrite/bisulfite dual-response fluorescent probe | |
CN108641713B (en) | Fluorescent probe for detecting hypochlorite ions and preparation method and application thereof | |
CN111944517B (en) | Conjugated hepta-boron dipyrrole fluorescent dye and synthetic method thereof | |
CN112812075A (en) | Preparation method and application of benzothiazole Schiff base-based fluorescent probe | |
Hu | Pyrazine-based G-quadruplex fluorescent probes: Transformation between aggregation-induced emission and disaggregation-induced emission via slight variations in structures | |
CN105154065A (en) | Fluorescence probe for identifying hydroxyl radicals rapidly and specifically as well as preparation method and application of fluorescence probe | |
CN108752275B (en) | pH fluorescent probe and preparation method and application thereof | |
Han et al. | A TBET-based ratiometric probe for Au 3+ and its application in living cells | |
CN111100151B (en) | Preparation method of probe for specifically detecting parallel configuration G-quadruplex DNA | |
CN111533761B (en) | Ratio type pH probe with organelle or protein targeting function and application thereof | |
CN114105927B (en) | Construction of benzopyran nitrile fluorescent molecular probe and in-vitro diagnosis application thereof | |
CN113121541B (en) | Synthesis and application of fluorescent probe capable of distinguishing gold ions Au3+ and palladium simultaneously | |
CN112409261B (en) | Bifunctional fluorescent probe for detecting Pd concentration and pH value and preparation and application thereof | |
CN106397316B (en) | A kind of fluorescence probe and its preparation method and application with charge transfer characteristic | |
CN116239518A (en) | Preparation and application of near infrared fluorescent molecular probe with ESIPT+AIE effect | |
CN108949159B (en) | Fluorescent probe for detecting palladium ions and synthetic method and application thereof | |
CN112500420A (en) | Double-color fluorescent probe and preparation method and application thereof | |
CN108047221A (en) | A kind of imide compound, synthetic method and its in H2O2Application in detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |